Abstract
Blood–brain barrier (BBB) constituted primarily by the capillary endothelial cells functions to maintain a constant environment for the brain, by preventing or slowing down the passage of a variety of blood-borne substances, such as serum proteins, chemical compounds, ions, and hormones from the circulation into the brain parenchyma. Various diseases such as brain tumors, epilepsy, and sepsis disturb the BBB integrity leading to enhanced permeability of brain microvessels. In animal models, a variety of experimental insults targeted to the BBB integrity have been shown to increase BBB permeability causing enhanced passage of molecules into the brain paranchyma by transcellular and/or paracellular pathways. This alteration can be demonstrated by intravascular infusion of exogenous tracers and subsequent detection of extravasated molecules in the brain tissue. A number of exogenous BBB tracers are available, and they can be used for functional and structural analysis of BBB permeability. In this chapter, we aimed to highlight the basic knowledge on the use of three most commonly performed tracers, namely Evans blue dye, sodium fluorescein, and horseradish peroxidase. The experimental methodologies that we use in our laboratory for the detection of these tracers by macroscopy, spectrophotometry, spectrophotofluorometry, and electron microscopy are also discussed. While tracing studies at the morphological level are mainly aimed at the identification and characterization of the tracers both in the barrier related cells and brain parenchyma, spectrophotometric and spectrophotofluorometric assays enable quantification of BBB permeability. The results of our studies that we performed using the mentioned tracers indicate that barrier type of endothelial cells in brain play an important role in paracellular and/or transcytoplasmic trafficking of macromolecules across BBB under various experimental settings, which may provide new insights in both designing approaches for the management of diseases with BBB breakdown and developing novel trans-BBB drug delivery strategies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Neuwelt, E. A., Abbott, N. J., Drewes, L., Smith, Q.R., Couraud, P. O., Chiocca, E. A., Audus, K. L., Greig, N. H., Doolittle, N. D. (1999) Cerebrovascular Biology and the various neural barriers: challenges and future directions. Neurosurgery 44, 604–608.
Gloor, S. M., Wachtel, M., Bolliger, M.F., Ishihara, H., Landmann, R., Frei. K. (2001) Molecular and cellular permeability control at the blood-brain barrier. Brain Res. Brain Res. Rev. 36, 258–264.
Abbott, N. J., Rönnbäck, L., Hansson, E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 1–53.
Correale, J., Villa, A. (2009) Cellular elements of the blood-brain barrier. Neurochem. Res. 34, 2067–2077.
Weiss, N., Miller, F., Cazaubon, S., Couraud, P. O. (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim. Biophys. Acta. 1788, 842–857.
Brightman, M. W., Reese, T. S. (1969) Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell Biol. 40, 648–677.
Begley, D. J., Brightman, M. W. (2003) Structural and functional aspects of the blood–brain barrier. Progr. Drug Res. 61, 39–78.
Abbott, N. J., Patabendige, A. A., Dolman, D. E., Yusof, S. R., Begley, D. J. (2010) Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13–25.
Rubin, L. L., Staddon, J. M. (1999) The cell biology of the blood-brain barrier. Annul. Rev. Neurosci. 22, 11–28.
Ek, C. J., Habgood, M. D., Dziegielewska, K. M., Potter, A., Saunders, N. R. (2001) Permeability and route of entry for lipid-insoluble molecules across brain barriers in developing Monodelphis domestica. J. Physiol. 536, 841–853.
Tuma, P. L., Hubbard, A. L. (2003) Transcytosis: crossing cellular barriers. Physiol. Rev. 83, 871–932.
Rosenberg, G. A., Yang, Y. (2007) Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg. Focus 22, E4.
Strbian, D., Durukan, A., Pitkonen, M., Marinkovic, I., Tatlisumak, E., Pedrono, E., Abo-Ramadan, U., Tatlisumak, T. (2008) The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 153, 175–181.
Hardebo, J. E., Johansson, B. B. (1980) Effect of an anion transport inhibitor on blood-brain barrier lesions during acute hypertension. Possible prevention of transendothelial vesicular transport. Acta Neuropathol. 51, 33–38.
Kaya, M., Kalayci, R., Küçük, M., Arican, N., Elmas, I., Kudat, H., Korkut, F. (2003) Effect of losartan on the blood-brain barrier permeability in diabetic hypertensive rats. Life Sci. 73, 3235–3244.
Dietrich, W.D., Alonso, O., Halley, M. (1994) Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J. Neurotrauma 11, 289–301.
Beaumont, A., Marmarou, A., Hayasaki, K., Barzo, P., Fatouros, P., Corwin, F., Marmarou, C., Dunbar, J. (2000) The permissive nature of blood brain barrier (BBB) opening in edema formation following traumatic brain injury. Acta Neurochir. Suppl. 76, 125–129.
Gurses, C., Ekizoglu, O., Orhan, N., Ustek, D., Arican, N., Ahishali, B., Elmas, I., Kucuk, M., Bilgic, B., Kemikler, G., Kalayci, R., Karadeniz, A., Kaya, M. (2009) Levetiracetam decreases the seizure activity and blood-brain barrier permeability in pentylenetetrazole-kindled rats with cortical dysplasia. Brain Res. 1281, 71–83.
Ndode-Ekane, X. E., Hayward, N., Gröhn, O., Pitkänen, A. (2010) Vascular changes in epilepsy: Functional consequences and association with network plasticity in pilocarpine-induced experimental epilepsy. Neuroscience 166, 312–332.
d’Avella, D., Cicciarello, R., Angileri, F. F., Lucerna, S., La Torre, D., Tomasello, F. (1998) Radiation-induced blood-brain barrier changes: pathophysiological mechanisms and clinical implications. Acta Neurochir. Suppl. 71, 282–294.
Kaya, M., Palanduz, A., Kalayci, R., Kemikler, G., Simsek, G., Bilgic, B., Ahishali, B., Arican, N., Kocyildiz, Z. C., Elmas, I., Kucuk, M., Karadeniz, A. (2004) Effects of Lipopolysaccharide on the Radiation-Induced Changes in the Blood-Brain Barrier and the Astrocytes. Brain Res. 1019, 105–112.
Wolman, M., Klatzo, I. and Chui, E. (1981) Evaluation of the dye-protein tracer in pathophysiology of the blood-brain barrier. Acta Neuropathol. (Berl.) 54, 55–61.
Clasen, R. A., Pandolfi, S., Hass, G. M. (1970) Vital staining, serum albumin and the blood-brain barrier. J. Neuropathol. Exp. Neurol. 29, 266–284.
Zuccarello, M., Anderson, D. K. (1989) Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats. Stroke 20, 367–371.
Kaya, M., Küçük, M., Bulut, R. K., Palandüz, Ş. (1999) Acute hyperglycemia augments blood-brain barrier damage in experimental status epilepticus. Neurosci. Res. Commun. 25, 111–119.
Kaya, M., Küçük, M., Kalaycı, R., Çimen, V., Gürses, C., Elmas, İ., Arıcan, N. (2001) Magnesium sullfate attenuates increased blood-brain barrier permeability during insulin-induced hypoglycemia in rats. Can. J. Physiol. and Pharmacol. 79, 793–798.
Kaya, M., Kalaycı, R., Arıcan, N., Küçük, M., Elmas, I. (2003-a) Effect of aluminum on the blood-brain barrier permeability during nitric oxide-blockade-induced chronic hypertension in rats. Biol. Trace Element Res. 92, 221–230.
Kaya, M., Gulturk, S., Elmas, I., Kalayci, R., Arican, N., Kocyildiz, Z.C., Kucuk, M., Yorulmaz, H., Sivas, A. (2004-a) The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Life Sci. 76, 201–212.
Esen, F., Erdem, T., Aktan, D., Orhan, M., Kaya, M., Eraksoy, H., Cakar, N., Telci, L. (2005) Effect of magnesium sulfate administration on blood–brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study. Crit. Care 9, R18–23.
Kalayci R, Kaya M, Ahishali B, Arican N, Elmas I, Kucuk M. Long-term L-NAME treatment potentiates the blood-brain barrier disruption during pentylenetetrazole-induced seizures in rats. Life Sci. 79(1):16–20, 2006.
Lo, W. D., McNeely, D. L., Boesel, C. W. (1991) Blood-brain barrier permeability in an experimental model of bacterial cerebritis. Neurosurgery 29, 888–892.
Murakami, K., Kawase, M., Kondo, T., Chan, P. H. (1998) Cellular accumulation of extravasated serum protein and DNA fragmentation following vasogenic edema. J. Neurotrauma 15, 825–835.
Akiyama, H., Kondoh, T., Kokunai, T., Nagashima, T., Saito, N., Tamaki, N. (2000) Blood-brain barrier formation of grafted human umbilical vein endothelial cells in athymic mouse brain. Brain Res. 858, 172–176.
Beach, V. L., Steinetz, B. G. 1961. Quantitative measurement of Evans blue space in the tissues of the rat: influence of 5-hydroxytryptamine antagonists and phenelzine on experimental inflammation. J. Pharmacol. Exp. Ther. 131, 400–406.
Kajiwara, K., Ito, H., Fukumoto, T. (1990) Lymphocyte infiltration into normal rat brain following hyperosmotic blood-brain barrier opening. J. Neuroimmunol. 27, 133–140.
Mikawa, S., Kinouchi, H., Kamii, H., Gobbel, G. T., Chen, S. F., Carlson, E., Epstein, C. J., Chan, P. H. (1996) Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice. J. Neurosurg. 85, 885–891.
Saria, A., Lundberg, J. M. (1983) Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J. Neurosci. Methods 8, 41–49.
Hatashita, S., Hoff, J. T. (1990) Brain edema and cerebrovascular permeability during cerebral ischemia in rats. Stroke 21, 582–288.
Gupta, A., Agarwal, R., Shukla, G. S. (1999) Functional impairment of blood-brain barrier following pesticide exposure during early development in rats. Hum. Exp. Toxicol. 18, 174–179.
Hooper, D. C., Kean R. B., Scott, G. S., Spitsin, S. V., Mikheeva, T., Morimoto, K., Bette, M., Röhrenbeck, A. M., Dietzschold, B., Weihe, E. (2001) The Central Nervous System Inflammatory Response to Neurotropic Virus Infection Is Peroxynitrite Dependent. The Journal of Immunol. 167, 3470–3477.
Erdlenbruch, B., Alipour, M., Fricker, G., Miller, D. S., Kugler, W., Eibl, H., Lakomek, M. (2003) Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries. Br. J. Pharmacol. 140, 1201–1210.
Natah, S. S., Mouihate, A., Pittman, Q. J., Sharkey, K. A. (2005) Disruption of the blood-brain barrier during TNBS colitis. Neurogastroenterol. Motil. 17, 433–46.
Kaya, M., Gurses, C., Kalayci, R., Ekizoglu, O., Ahishali, B., Orhan, N., Oku, B., Arican, N., Ustek, D., Bilgic, B., Elmas, I., Kucuk, M., Kemikler, G. (2008) Morphological and functional changes of blood-brain barrier in kindled rats with cortical dysplasia. Brain Res. 1208, 181–191.
Reese, T. S., Karnovsky, M. J. (1967) Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34, 207–217.
Bolwig, T. G., Hertz, M. M., Westergaard, E. (1977) Acute hypertension causing blood-brain barrier breakdown during epileptic seizures. Acta Neurol. Scand. 56, 335–342.
Sheikov, N., McDannold, N., Sharma, S., Hynynen, K. (2008) Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med. Biol. 34, 1093–1104.
Westergaard, E., Brightman, M. W. (1973) Transport of protein across normal cerebral arteriols. J. Comp. Neurol. 152, 17–44.
Reyners, H., de Reyners, E. G., Jadin, J. M., Maisin, J. R. (1975) An ultrastructural quantitative method for the evaluation of the permeability to horseradish peroxidase of cerebral cortex endothelial cells of the rat. Cell Tissue Res. 157, 93–99.
Broadwell, R. D., Charlton, H. M., Balin, B. J., Salcman, M. (1987) Angioarchitecture of the CNS, pituitary gland, and intracerebral grafts revealed with peroxidase cytochemistry. J. Comp. Neurol. 260, 47–62.
Villegas, J. C., Broadwell, R.D. (1993) Transcytosis of protein through the mammalian cerebral epithelium and endothelium II. Adsorptive trancytosis of WGA-HRP and the blood-brain and brain-blood barriers. J. Neurocytol. 22, 67–80.
Nag, S. (1998) Blood-brain barrier permeability measured with histochemisty. Ed. Pardridge WM. Introduction to the blood-brain barrier-Methodology, biology and pathology. pp. 113–121, Cambridge University Press.
Nag, S. (2003) Pathophysiology of blood-brain barrier breakdown. Ed: Nag, S. The Blood-brain barrier-Biology and research protocols – Method in molecular medicine. Chapter 6, pp: 97–119, Humana press.
Nag, S. (2003a) Blood-brain barrier permeability using tracers and immunohistochemistry. Ed: Nag, S. The Blood-brain barrier-Biology and research protocols – Method in molecular medicine. Chapter 8, pp: 133–144, Humana press.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kaya, M., Ahishali, B. (2011). Assessment of Permeability in Barrier Type of Endothelium in Brain Using Tracers: Evans Blue, Sodium Fluorescein, and Horseradish Peroxidase. In: Turksen, K. (eds) Permeability Barrier. Methods in Molecular Biology, vol 763. Humana Press. https://doi.org/10.1007/978-1-61779-191-8_25
Download citation
DOI: https://doi.org/10.1007/978-1-61779-191-8_25
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-190-1
Online ISBN: 978-1-61779-191-8
eBook Packages: Springer Protocols